Claim OwnershipAUAUniversity
Subscribed: 73Played: 3,087
Subscribe
© All rights reserved
Description
The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
425 Episodes
Reverse
MIBC Treatment Landscape (Republished)
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jen-Jane Liu, MD, FACS
CME Available: https://cme.auanet.org/URL/GUPOD252
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Integrate immunotherapy and targeted therapy into the multimodal management of MIBC, selecting appropriate regimens and sequencing strategies based on current guidelines, clinical trial data, and patient-specific factors.
2. Evaluate the clinical role, mechanisms of action, and evidence base for targeted therapies in MIBC, including biomarker-driven selection to support personalized treatment planning.
3. Develop and apply practical approaches for preventing, monitoring, and managing immune-related adverse events and other toxicities associated with immunotherapy and targeted therapy to optimize patient safety, adherence, and quality of life.
AUA2025: Key Takeaways: Bladder Cancer
Presenters: Patrick Hensley, MD & Janet Kukreja, MD
Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit https://cme.auanet.org/URL/US2026
Adjuvant Therapy for Renal Cell Carcinoma
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Daniel Shapiro, MD, FACS
CME Available:
https://cme.auanet.org/URL/RCCPOD261
ACKNOWLEDGEMENTS:
Support provided by an independent educational grant from:
Merck & Co., Inc.
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Define adjuvant therapy, review current clinical guidelines, and recognize the current landscape of treatment options for patients with RCC.
2. Compare and contrast different adjuvant therapies available for RCC, including targeted therapies and immunotherapies.
3. Identify common side effects associated with adjuvant therapies for RCC and provide strategies for managing and mitigating these adverse events in clinical practice.
4. Discuss ongoing clinical trials and new therapeutic targets under investigation for adjuvant treatment of RCC.
Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Karen L. Stern, MD
Update Series: The Role of Nephrectomy in Advanced Kidney Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Sarah P. Psutka, M.D., M.S., F.A.C.S.
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit CME.auanet.org
AI for Prostate Cancer Treatment Planning
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Wayne G. Brisbane, MD
AUA Guidelines: Salvage Therapy for Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Yaw Nyame, MD, MS, MBA
Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol. 2024;211(4):509-517. https://www.auajournals.org/doi/10.1097/JU.0000000000003892
Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol. 2024;211(4):518-525. https://www.auajournals.org/doi/10.1097/JU.0000000000003891
Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part III: salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol. 2024;211(4):526-532. https://www.auajournals.org/doi/10.1097/JU.0000000000003890
AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Elise JB De, MD & Dane Johnson, MD
Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach. J Urol. 0(0). doi:10.1097/JU.0000000000004564. https://www.auajournals.org/doi/10.1097/JU.0000000000004564
Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Urol. 0(0). doi:10.1097/JU.0000000000004565. https://www.auajournals.org/doi/10.1097/JU.0000000000004565
Lai HH, Pontari MA, Argoff CE, at al. Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain. J Urol. 0(0). doi:10.1097/JU.0000000000004566. https://www.auajournals.org/doi/10.1097/JU.0000000000004566
NMIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Janet Kukreja, MD, MPH, FACS
CME Available: auau.auanet.org/node/44076
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Select and implement immunotherapy regimens for patients with NMIBC in accordance with current AUA Guideline recommendations, tailoring treatment choices to tumor characteristics and individual patient needs.
2. Incorporate FDA-approved gene therapy options into NMIBC management by aligning therapeutic approaches with patient-specific factors, disease risk profile, and evolving clinical evidence.
3. Develop and integrate practical strategies to anticipate, monitor, and manage treatment-related side effects and immune-related adverse events in NMIBC, ensuring patient safety and treatment continuity.
MIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jen-Jane Liu, MD, FACS
CME Available: auau.auanet.org/node/44077
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Integrate immunotherapy and targeted therapy into the multimodal management of MIBC, selecting appropriate regimens and sequencing strategies based on current guidelines, clinical trial data, and patient-specific factors.
2. Evaluate the clinical role, mechanisms of action, and evidence base for targeted therapies in MIBC, including biomarker-driven selection to support personalized treatment planning.
3. Develop and apply practical approaches for preventing, monitoring, and managing immune-related adverse events and other toxicities associated with immunotherapy and targeted therapy to optimize patient safety, adherence, and quality of life.
AUA Guidelines: Genitourinary Syndrome of Menopause
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Tracey S. Wilson, MD & Una J. Lee, MD
Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
Kaufman MR, Ackerman LA, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 0(0). doi:10.1097/JU.0000000000004589. https://www.auajournals.org/doi/10.1097/JU.0000000000004589
LG-IR-NMIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Chad R. Ritch, MD, MBA, FACS
CME Available: auau.auanet.org/node/44036
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Differentiate between traditional and emerging intravesical therapies for LG-IR-NMIBC, considering mechanism of action, administration schedules, and patient eligibility to support individualized treatment planning.
2. Incorporate into practice shared decision-making strategies that align clinical recommendations with patient values, preferences, and quality-of-life considerations in the management of LG-IR-NMIBC.
3. Utilize practical approaches for integrating intravesical therapy into routine clinical workflows, including coordination among multidisciplinary teams, patient education, and follow-up to optimize adherence and outcomes.
Core Curriculum: Surgical Management of Urolithiasis
AUA Urology Core Curriculum: auau.auanet.org/core
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Marcelino E. Rivera, MD and T. Max Shelton, MD
Outline:
Segment 1: Acute Stone Event and Radiographic Evaluation
Segment 2: Shock Wave Lithotripsy
Segment 3: Ureteroscopy
Segment 4: Percutaneous Nephrolithotomy
Segment 5: Intracorporeal Lithotripsy
Segment 6: Special Considerations
AUA2025: Key Takeaways: BPH
Presenters: Bilal Chughtai, MD & Dean S. Elterman, MD, MSc, FRCSC
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction
Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS
AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: A. Lenore Ackerman, MD, PhD & Melissa R. Kaufman, MD, PhD
Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025)
Ackerman AL, Bradley M, D’Anci KE, Hickling D, Kim SK, Kirkby E. Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004723
Anorectal Malformation
AUA Urology Core Curriculum: auau.auanet.org/core
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Christina Ho, MD and Molly E. Fuchs, MD
Outline:
Segment 1: Anorectal Malformation Overview/Background
Segment 2: Initial Evaluation and Management
Segment 3: Cloacal Malformations
Segment 4: Long-Term Bladder Management & Concern for CKD
Segment 5: Other Considerations
AUA2025: Key Takeaways: Endourology/Stones Highlights
Presenters: Davis Viprakasit, MD & Stephen Nakada MD, FACS, FRCS
Update Series (2025) Lesson 30: Beyond Ureteropelvic Junction: Case-Based Tips and Tricks in Robotic Ureteral Stricture Reconstructive Surgery
Now in its 44th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit AUAnet.org/Update25
Comments
Download from Google Play
Download from App Store
United States